Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Bio-Techne (TECH) Long-Term Debt Issuances (2016 - 2025)

Bio-Techne has reported Long-Term Debt Issuances over the past 10 years, most recently at $66.0 million for Q2 2025.

  • Quarterly results put Long-Term Debt Issuances at $66.0 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $104.0 million (down 53.78% YoY), and the annual figure for FY2025 was $104.0 million, down 53.78%.
  • Long-Term Debt Issuances for Q2 2025 was $66.0 million at Bio-Techne, up from $38.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for TECH hit a ceiling of $449.7 million in Q3 2022 and a floor of $10.0 million in Q3 2021.
  • Median Long-Term Debt Issuances over the past 4 years was $65.5 million (2023), compared with a mean of $129.5 million.
  • Biggest five-year swings in Long-Term Debt Issuances: surged 4396.61% in 2022 and later crashed 64.42% in 2023.
  • Bio-Techne's Long-Term Debt Issuances stood at $40.0 million in 2021, then surged by 1024.15% to $449.7 million in 2022, then tumbled by 85.54% to $65.0 million in 2023, then increased by 1.54% to $66.0 million in 2025.
  • The last three reported values for Long-Term Debt Issuances were $66.0 million (Q2 2025), $38.0 million (Q1 2025), and $65.0 million (Q4 2023) per Business Quant data.